Search research articles
Contact Us
Filters
Showing results (181-190 of 274) with videos related to
Page
of 28
Sort By:
The American Journal of Managed Care
|
July 28, 2001
Managing healthcare resources appropriately. Roundtable discussion
I E Leppik, J A French, G K Bergey, et al.
Neurology
|
September 30, 2016
Deconstructing tolerance with clobazam: Post hoc analyses from an open-label extension study
Barry E Gidal, Robert T Wechsler, Raman Sankar, et al.
Physical Review. D, Particles and Fields
|
October 1, 1995
Nuclear dependence of J/ psi production by 800 GeV/c protons near xF=0
Leitch, Brown, Carey, et al.
The Lancet. Neurology
|
February 16, 2016
Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial
Michael D Privitera, Timothy E Welty, Barry E Gidal, et al.
Epilepsia
|
July 14, 2022
Considerations for determining the efficacy of new antiseizure medications in children age 1 month to younger than 2 years
Jacqueline A French, Elena Cleary, Dennis Dlugos, et al.
Physical Review. D, Particles and Fields
|
April 1, 1989
Limits on new-lepton pairs (L-,L0) with arbitrary neutrino mass
Stoker, Perl, Abrams, et al.
Epilepsy Currents
|
September 27, 2018
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
Andres M Kanner, Eric Ashman, David Gloss, et al.
Physical Review. D, Particles and Fields
|
January 1, 1996
Erratum: Measurement of J/ psi and psi ' production in 800 GeV/c proton-gold collisions
Schub, Jansen, Mishra, et al.
JAMA Neurology
|
June 28, 2017
Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial
Michel Berg, Timothy E Welty, Barry E Gidal, et al.
Acta Neurologica Scandinavica
|
May 8, 2018
Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate
B E Gidal, M P Jacobson, E Ben-Menachem, et al.
Page
of 28
Search research articles
Search
Showing results (181-190 of 274) with videos related to
Sort By:
Page
of 28
The American Journal of Managed Care
|
July 28, 2001
Managing healthcare resources appropriately. Roundtable discussion
I E Leppik, J A French, G K Bergey, et al.
Neurology
|
September 30, 2016
Deconstructing tolerance with clobazam: Post hoc analyses from an open-label extension study
Barry E Gidal, Robert T Wechsler, Raman Sankar, et al.
Physical Review. D, Particles and Fields
|
October 1, 1995
Nuclear dependence of J/ psi production by 800 GeV/c protons near xF=0
Leitch, Brown, Carey, et al.
The Lancet. Neurology
|
February 16, 2016
Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial
Michael D Privitera, Timothy E Welty, Barry E Gidal, et al.
Epilepsia
|
July 14, 2022
Considerations for determining the efficacy of new antiseizure medications in children age 1 month to younger than 2 years
Jacqueline A French, Elena Cleary, Dennis Dlugos, et al.
Physical Review. D, Particles and Fields
|
April 1, 1989
Limits on new-lepton pairs (L-,L0) with arbitrary neutrino mass
Stoker, Perl, Abrams, et al.
Epilepsy Currents
|
September 27, 2018
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
Andres M Kanner, Eric Ashman, David Gloss, et al.
Physical Review. D, Particles and Fields
|
January 1, 1996
Erratum: Measurement of J/ psi and psi ' production in 800 GeV/c proton-gold collisions
Schub, Jansen, Mishra, et al.
JAMA Neurology
|
June 28, 2017
Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial
Michel Berg, Timothy E Welty, Barry E Gidal, et al.
Acta Neurologica Scandinavica
|
May 8, 2018
Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate
B E Gidal, M P Jacobson, E Ben-Menachem, et al.
Page
of 28